Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

Why? Because of an outdated Securities and Exchange Commission (SEC) rule that limits participation in private market ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.